Nephrology and Urology Devices Market Size, Share & Trends Analysis Report By Products (Ureteral Catheters, Percutaneous Nephrostomy (PCN) Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Nephrology and Urology Devices Market Size

The global nephrology and urology devices market size was valued at USD 6.49 billion in 2025 and is projected to grow from USD 6.96 billion in 2026 to USD 12.11 billion by 2034, registering a CAGR of 7.18% during the forecast period from 2026 to 2034. Asia Pacific dominated the nephrology and urology devices market with a market share of 35.4% in 2025.

An unhealthy lifestyle, like lack of physical activity and alcohol consumption, and a rise in smoking and obesity with dietary irregularities are some factors resulting in neurological and urological disorders, simulating market growth.

Nephrology and urology devices are medical devices specifically designed and used to diagnose, treat, and manage conditions related to the kidneys and urinary system. These devices encompass instruments, equipment, and implants that aid in various urological and nephrological procedures. In urology, these devices diagnose and treat conditions affecting the kidneys, bladder, ureters, and urethra, all of the urinary system. Some commonly used urology devices include urinary catheters, stents, urological endoscopes, lithotripters (used for non-invasive kidney stone treatment), urinary incontinence devices, and prostate implants for the management of conditions such as benign prostatic hyperplasia (BPH) and prostate cancer.

In nephrology, these devices diagnose and treat kidney-related conditions, including renal failure, kidney stones, and kidney transplantation. Hemodialysis machines, which filter waste products and excess blood from blood in patients with kidney failure, are among the most well-known nephrology devices. Other nephrology devices include peritoneal dialysis systems, which use the lining of the abdominal cavity to filter waste products, and devices used for kidney biopsy and kidney stone retrieval. Nephrology and urology devices are crucial in managing various urological and nephrological conditions, helping improve patient outcomes, enhancing diagnostic accuracy, and providing effective treatment options. These devices are developed and manufactured by medical device companies focusing on advancing technology, ensuring patient safety, and enhancing the quality of care in nephrology and urology specialties.

Products Insights

The market is bifurcated into ureteral catheters, percutaneous nephrostomy (PCN) catheters, urinary stents, stone baskets, urology guidewires, renal dilators, and others. The ureteral catheters segment dominates the global nephrology and urology devices market share and is projected to exhibit a CAGR of 7.5% over the forecast period. Ureteral catheters are used for diagnostic and therapeutic procedures, such as relieving urinary retention, providing irrigation, and instilling medication. Furthermore, ureteral catheters inject contrast media in ureteral occlusion, deliver irrigation fluids to the ureter, and access or exchange ancillary devices, including guidewires and drainage of fluids from the urinary tract. The increasing prevalence of colorectal cancer and acute kidney injuries are a few factors driving market growth. For example, according to the International Agency for Research on Cancer, 2018, around 61,846 people in Africa were diagnosed with colorectal cancer.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Insights

Asia-Pacific is the most significant global nephrology and urology devices market shareholder and is estimated to grow at a CAGR of 7.2% over the forecast period. The increasing prevalence of Benign Prostatic Hyperplasia (BPH), spinal cord injury, and Urinary Tract Infection drives the growth of the Asia Pacific nephrology and urology devices market. One of the most common infectious infections in this area is UTI. It is linked to substantial morbidity and death, particularly in hospitals, and results in a substantial financial burden on the community. Thus, the rising prevalence of UTI in women with increasing age, parity, obesity, vaginal deliveries, surgery, constipation, and chronic respiratory problems, such as cough, is driving market growth in Asia-Pacific.

In addition, increasing awareness about bladder cancer drives the market in countries like Japan and China. For instance, according to NCBI, infrequent voiding of the bladder to avoid public toilets contributes to several urinary issues in individuals in Japan. Women aged 18 to 25 in the country suffer from Lower Urinary Tract Symptoms (LUTSs). An increasing number of people suffering from an Overactive Bladder (OAB) is driving growth in Asian countries such as South Korea. According to NCBI, 5.2% of women in South Korea experienced OAB. This condition has several symptoms, typically characterized by urgency, with or without urge, urinary incontinence, and frequency and nocturia

Unlock Regional Insightsto access country-level data, & regional trends.

Middle East and North Africa Nephrology and Urology Devices Market Trends

The Middle East and North Africa are anticipated to exhibit a CAGR of 6.9% over the forecast period. The increasing incidence of urinary disorders and bladder issues and the rising prevalence of OAB are a few factors contributing to market growth in the Middle East and North African region. Factors such as the rise in stress and sexual activities can be attributed to the increasing prevalence of these diseases. These urinary disorders also affect the quality of life. The abovementioned factors will likely drive market growth in the MENA region during the forecast period.

Moreover, factors like the rising prevalence of diabetes and hypertension raise the risk of developing urology diseases, which is expected to increase demand for nephrology and urology devices in the region. For example, as per the International Diabetes Federation, 55 million adults were living with diabetes in the International Diabetes Federation Middle East and North Africa (IDF MENA) region in 2019, which is estimated to increase to 108 million by 2045.

• In GCC, Extreme temperatures, lack of hydration among people, a sedentary lifestyle, and diseases like hypertension and diabetes are a few factors increasing the risk of urological disorders among the GCC population. According to the Oman Ministry of Health’s annual report, in 2017, around 6,360 people were diagnosed with diabetes. Furthermore, per the Institute for Health Metrics and Evaluation, deaths due to chronic kidney disease in Bahrain increased by 50.1% from 2007 to 2017.
• In the Kingdom of Saudi Arabia, as per export.gov, the healthcare budget has increased from USD 42.4 billion in 2018 to USD 46 billion in 2019, which equates to around 15% of the total government spending. According to the WHO, 5% of the total deaths in Saudi Arabia were due to diabetes. Furthermore, as per the International Diabetes Federation (IDF), 18.3% of adults in Saudi Arabia had diabetes in 2016. Thus, increasing healthcare spending by the government and the rising prevalence of diseases like diabetes and hypertension are a few variables causing the industry to rise.

List of Key and Emerging Players in Nephrology and Urology Devices Market